{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:18:43Z","timestamp":1781299123465,"version":"3.54.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00726-023-03249-6","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T20:08:47Z","timestamp":1676318927000},"page":"579-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phenolic compounds as histone deacetylase inhibitors: binding propensity and interaction insights from molecular docking and dynamics simulations"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-108X","authenticated-orcid":false,"given":"Abdullahi Ibrahim","family":"Uba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-7823","authenticated-orcid":false,"given":"Gokhan","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,12]]},"reference":[{"key":"3249_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158141","author":"RK Alseksek","year":"2022","unstructured":"Alseksek RK, Ramadan WS, Saleh E, El-Awady R (2022) The role of HDACs in the response of cancer cells to cellular stress and the potential for therapeutic intervention. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23158141","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3249_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jnutbio.2012.07.001","volume":"24","author":"A Berger","year":"2013","unstructured":"Berger A, Venturelli S, Kallnischkies M, B\u00f6cker A, Busch C, Weiland T, Noor S, Leischner C, Weiss TS, Lauer UM, Bischoff SC, Bitzer M (2013) Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. J Nutr Biochem 24(6):977\u2013985. https:\/\/doi.org\/10.1016\/j.jnutbio.2012.07.001","journal-title":"J Nutr Biochem"},{"key":"3249_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4751806","volume":"2018","author":"S Biswas","year":"2018","unstructured":"Biswas S, Reddy ND, Jayashree BS, Rao CM (2018) Evaluation of novel 3-hydroxyflavone analogues as HDAC inhibitors against colorectal cancer. Adv Pharmacol Sci 2018:1\u201314. https:\/\/doi.org\/10.1155\/2018\/4751806","journal-title":"Adv Pharmacol Sci"},{"issue":"12","key":"3249_CR4","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schi\u00f6th HB (2021) Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol 87(12):4577\u20134597. https:\/\/doi.org\/10.1111\/bcp.14889","journal-title":"Br J Clin Pharmacol"},{"issue":"14","key":"3249_CR5","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1016\/j.bmc.2009.05.042","volume":"17","author":"G Bora-Tatar","year":"2009","unstructured":"Bora-Tatar G, Dayanga\u00e7-Erden D, Demir AS, Dalkara S, Yelek\u00e7i K, Erdem-Yurter H (2009) Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies. Bioorg Med Chem 17(14):5219\u20135228. https:\/\/doi.org\/10.1016\/j.bmc.2009.05.042","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"3249_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molcel.2018.06.003","volume":"71","author":"S Bornel\u00f6v","year":"2018","unstructured":"Bornel\u00f6v S, Reynolds N, Xenophontos M, Gharbi S, Johnstone E, Floyd R, Ralser M, Signolet J, Loos R, Dietmann S, Bertone P, Hendrich B (2018) The nucleosome remodeling and deacetylation complex modulates chromatin structure at sites of active transcription to fine-tune gene expression. Mol Cell 71(1):56-72.e54. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.003","journal-title":"Mol Cell"},{"issue":"39","key":"3249_CR7","doi-asserted-by":"publisher","first-page":"26694","DOI":"10.1074\/jbc.M803514200","volume":"283","author":"MJ Bottomley","year":"2008","unstructured":"Bottomley MJ, Lo Surdo P, Di Giovine P, Cirillo A, Scarpelli R, Ferrigno F, Jones P, Neddermann P, De Francesco R, Steink\u00fchler C, Gallinari P, Carf\u00ed A (2008) Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 283(39):26694\u201326704. https:\/\/doi.org\/10.1074\/jbc.M803514200","journal-title":"J Biol Chem"},{"issue":"4","key":"3249_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ddr.21927","volume":"83","author":"O Cetin","year":"2022","unstructured":"Cetin O, Sari S, Erdem-Yurter H, Bora G (2022) Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition. Drug Dev Res 83(4):993\u20131002. https:\/\/doi.org\/10.1002\/ddr.21927","journal-title":"Drug Dev Res"},{"issue":"6","key":"3249_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1742-7843.2007.00142.x","volume":"101","author":"Y Chen","year":"2007","unstructured":"Chen Y, Shu W, Chen W, Wu Q, Liu H, Cui G (2007) Curcumin, both histone deacetylase and p300\/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 101(6):427\u2013433. https:\/\/doi.org\/10.1111\/j.1742-7843.2007.00142.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"3249_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/13880209.2020.1738503","volume":"58","author":"L Dai","year":"2020","unstructured":"Dai L, Chen L, Wang W, Lin P (2020) Resveratrol inhibits ACHN cells via regulation of histone acetylation. Pharm Biol 58(1):231\u2013238. https:\/\/doi.org\/10.1080\/13880209.2020.1738503","journal-title":"Pharm Biol"},{"key":"3249_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbamcr.2014.11.004","volume":"2","author":"S Dhar","year":"2015","unstructured":"Dhar S, Kumar A, Li K, Tzivion G, Levenson AS (2015) Resveratrol regulates PTEN\/Akt pathway through inhibition of MTA1\/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta 2:265\u2013275. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.11.004","journal-title":"Biochim Biophys Acta"},{"key":"3249_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073097","author":"C Gaetano","year":"2013","unstructured":"Gaetano C, Venturelli S, Berger A, B\u00f6cker A, Busch C, Weiland T, Noor S, Leischner C, Schleicher S, Mayer M, Weiss TS, Bischoff SC, Lauer UM, Bitzer M (2013) Resveratrol as a pan-HDAC inhibitor alters the acetylation status of jistone proteins in human-derived hepatoblastoma cells. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0073097","journal-title":"PLoS ONE"},{"issue":"16","key":"3249_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.4155\/fmc-2018-0020","volume":"10","author":"SA Ganai","year":"2018","unstructured":"Ganai SA, Farooq Z, Banday S, Altaf M (2018) In silico approaches for investigating the binding propensity of apigenin and luteolin against class I HDAC isoforms. Future Med Chem 10(16):1925\u20131945. https:\/\/doi.org\/10.4155\/fmc-2018-0020","journal-title":"Future Med Chem"},{"issue":"28","key":"3249_CR14","doi-asserted-by":"publisher","first-page":"25748","DOI":"10.1074\/jbc.M111871200","volume":"277","author":"L Gao","year":"2002","unstructured":"Gao L, Cueto MA, Asselbergs F, Atadja P (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277(28):25748\u201325755. https:\/\/doi.org\/10.1074\/jbc.M111871200","journal-title":"J Biol Chem"},{"issue":"9","key":"3249_CR15","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1021\/acs.jmedchem.8b01936","volume":"62","author":"M G\u00e9raldy","year":"2019","unstructured":"G\u00e9raldy M, Morgen M, Sehr P, Steimbach RR, Moi D, Ridinger J, Oehme I, Witt O, Malz M, Nogueira MS, Koch O, Gunkel N, Miller AK (2019) Selective inhibition of histone deacetylase 10: hydrogen bonding to the gatekeeper residue is implicated. J Med Chem 62(9):4426\u20134443. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01936","journal-title":"J Med Chem"},{"issue":"18","key":"3249_CR16","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1128\/mcb.21.18.6091-6101.2001","volume":"21","author":"MG Guenther","year":"2001","unstructured":"Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21(18):6091\u20136101. https:\/\/doi.org\/10.1128\/mcb.21.18.6091-6101.2001","journal-title":"Mol Cell Biol"},{"issue":"9","key":"3249_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nchembio.2134","volume":"12","author":"Y Hai","year":"2016","unstructured":"Hai Y, Christianson DW (2016) Histone deacetylase 6 structure and molecular basis of catalysis and inhibition. Nat Chem Biol 12(9):741\u2013747. https:\/\/doi.org\/10.1038\/nchembio.2134","journal-title":"Nat Chem Biol"},{"key":"3249_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15368","author":"Y Hai","year":"2017","unstructured":"Hai Y, Shinsky SA, Porter NJ, Christianson DW (2017) Histone deacetylase 10 structure and molecular function as a polyamine deacetylase. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms15368","journal-title":"Nat Commun"},{"issue":"10","key":"3249_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.14715\/cmb\/2018.64.10.22","volume":"64","author":"L Hongtao","year":"2018","unstructured":"Hongtao L, Xiaoqi G, Junni L, Feng X, Guodong B, Liang Y (2018) Chlorogenic-induced inhibition of non-small cancer cells occurs through regulation of histone deacetylase 6. Cell Mol Biol (noisy-Le-Grand) 64(10):134\u2013139. https:\/\/doi.org\/10.14715\/cmb\/2018.64.10.22","journal-title":"Cell Mol Biol (noisy-Le-Grand)"},{"issue":"20","key":"3249_CR20","doi-asserted-by":"publisher","first-page":"15254","DOI":"10.1074\/jbc.M908988199","volume":"275","author":"E Hu","year":"2000","unstructured":"Hu E, Chen Z, Fredrickson T, Zhu Y, Kirkpatrick R, Zhang G-F, Johanson K, Sung C-M, Liu R, Winkler J (2000) Cloning and characterization of a novel human class I Histone deacetylase that functions as a transcription repressor. J Biol Chem 275(20):15254\u201315264. https:\/\/doi.org\/10.1074\/jbc.M908988199","journal-title":"J Biol Chem"},{"issue":"29","key":"3249_CR21","doi-asserted-by":"publisher","first-page":"18237","DOI":"10.1074\/jbc.M115.661058","volume":"290","author":"GM Hudson","year":"2015","unstructured":"Hudson GM, Watson PJ, Fairall L, Jamieson AG, Schwabe JWR (2015) Insights into the recruitment of class IIa histone deacetylases (HDACs) to the SMRT\/NCoR transcriptional repression complex. J Biol Chem 290(29):18237\u201318244. https:\/\/doi.org\/10.1074\/jbc.M115.661058","journal-title":"J Biol Chem"},{"issue":"14","key":"3249_CR22","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1080\/07391102.2018.1521747","volume":"37","author":"A Ibrahim Uba","year":"2019","unstructured":"Ibrahim Uba A, Yelek\u00e7i K (2019) Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. J Biomol Struct Dyn 37(14):3627\u20133636. https:\/\/doi.org\/10.1080\/07391102.2018.1521747","journal-title":"J Biomol Struct Dyn"},{"key":"3249_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111784","author":"YG Jang","year":"2018","unstructured":"Jang YG, Hwang KA, Choi KC (2018) Rosmarinic acid, a component of rosemary tea, induced the cell cycle arrest and apoptosis through modulation of HDAC2 expression in prostate cancer cell lines. Nutrients. https:\/\/doi.org\/10.3390\/nu10111784","journal-title":"Nutrients"},{"key":"3249_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108444","author":"Y-G Jang","year":"2020","unstructured":"Jang Y-G, Ko E-B, Choi K-C (2020) Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. Journal Nutr Biochem. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108444","journal-title":"Journal Nutr Biochem"},{"issue":"12","key":"3249_CR25","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1093\/nar\/gks189","volume":"40","author":"N Jayathilaka","year":"2012","unstructured":"Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz JA, Noridomi K, Philips MA, Lei X, He J, Ye J, Gao T, Petasis NA, Chen L (2012) Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res 40(12):5378\u20135388. https:\/\/doi.org\/10.1093\/nar\/gks189","journal-title":"Nucleic Acids Res"},{"key":"3249_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-144","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA (2011) Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-11-144","journal-title":"BMC Cancer"},{"issue":"1","key":"3249_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2015","unstructured":"Lee J, Cheng X, Swails JM, Yeom MS, Eastman PK, Lemkul JA, Wei S, Buckner J, Jeong JC, Qi Y, Jo S, Pande VS, Case DA, Brooks CL, MacKerell AD, Klauda JB, Im W (2015) CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12(1):405\u2013413. https:\/\/doi.org\/10.1021\/acs.jctc.5b00935","journal-title":"J Chem Theory Comput"},{"key":"3249_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026831","author":"Y Li","year":"2016","unstructured":"Li Y, Seto E (2016) HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a026831","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3249_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12079","author":"Y Li","year":"2012","unstructured":"Li Y, Shin D, Kwon SH (2012) Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. FEBS J. https:\/\/doi.org\/10.1111\/febs.12079","journal-title":"FEBS J"},{"issue":"5","key":"3249_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1745-7254.2005.00081.x","volume":"26","author":"H-l Liu","year":"2005","unstructured":"Liu H-l, Chen Y, Cui G-h, Zhou J-f (2005) Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 26(5):603\u2013609. https:\/\/doi.org\/10.1111\/j.1745-7254.2005.00081.x","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"3249_CR31","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1021\/bi101859k","volume":"50","author":"PM Lombardi","year":"2011","unstructured":"Lombardi PM, Angell HD, Whittington DA, Flynn EF, Rajashankar KR, Christianson DW (2011) Structure of prokaryotic polyamine deacetylase reveals evolutionary functional relationships with eukaryotic histone deacetylases. Biochemistry 50(11):1808\u20131817. https:\/\/doi.org\/10.1021\/bi101859k","journal-title":"Biochemistry"},{"key":"3249_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21111608","author":"H Losson","year":"2016","unstructured":"Losson H, Schnekenburger M, Dicato M, Diederich M (2016) Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer. Molecules. https:\/\/doi.org\/10.3390\/molecules21111608","journal-title":"Molecules"},{"issue":"7","key":"3249_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1021\/acs.jcim.7b00190","volume":"57","author":"G Mart\u00ednez-Rosell","year":"2017","unstructured":"Mart\u00ednez-Rosell G, Giorgino T, De Fabritiis G (2017) PlayMolecule proteinprepare: a web application for protein preparation for molecular dynamics simulations. J Chem Inf Model 57(7):1511\u20131516. https:\/\/doi.org\/10.1021\/acs.jcim.7b00190","journal-title":"J Chem Inf Model"},{"key":"3249_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/genes11050556","author":"G Milazzo","year":"2020","unstructured":"Milazzo G, Mercatelli D, Di Muzio G, Triboli L, De Rosa P, Perini G, Giorgi FM (2020) Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability. Genes. https:\/\/doi.org\/10.3390\/genes11050556","journal-title":"Genes"},{"issue":"Web Server","key":"3249_CR35","doi-asserted-by":"publisher","first-page":"W622","DOI":"10.1093\/nar\/gkq325","volume":"38","author":"MA Miteva","year":"2010","unstructured":"Miteva MA, Guyon F, Tuffery P (2010) Frog2: Efficient 3D conformation ensemble generator for small compounds. Nucleic Acids Res 38(Web Server):W622\u2013W627. https:\/\/doi.org\/10.1093\/nar\/gkq325","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"3249_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2018.04.007","volume":"25","author":"C Moreno-Yruela","year":"2018","unstructured":"Moreno-Yruela C, Galleano I, Madsen AS, Olsen CA (2018) Histone deacetylase 11 Is an \u03b5-N-myristoyllysine hydrolase. Cell Chem Biol 25(7):849-856.e848. https:\/\/doi.org\/10.1016\/j.chembiol.2018.04.007","journal-title":"Cell Chem Biol"},{"issue":"16","key":"3249_CR37","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"11\u201312","key":"3249_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0898-6568(00)00131-5","volume":"12","author":"A Muslin","year":"2000","unstructured":"Muslin A (2000) 14\u20133-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12(11\u201312):703\u2013709. https:\/\/doi.org\/10.1016\/s0898-6568(00)00131-5","journal-title":"Cell Signal"},{"key":"3249_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134014","author":"N Namwan","year":"2022","unstructured":"Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit L-o, Samankul A, Leerat C, Senawong T (2022) HDAC inhibitory and anti-cancer activities of curcumin and curcumin derivative CU17 against human lung cancer A549 cells. Molecules. https:\/\/doi.org\/10.3390\/molecules27134014","journal-title":"Molecules"},{"issue":"7","key":"3249_CR40","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ptr.5620","volume":"30","author":"V Panda","year":"2016","unstructured":"Panda V, Laddha A, Nandave M, Srinath S (2016) Dietary phenolic acids ofmacrotyloma uniflorum(Horse Gram) protect the rat heart against isoproterenol-induced myocardial infarction. Phytother Res 30(7):1146\u20131155. https:\/\/doi.org\/10.1002\/ptr.5620","journal-title":"Phytother Res"},{"issue":"12","key":"3249_CR41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/mc.20866","volume":"51","author":"M Pandey","year":"2012","unstructured":"Pandey M, Kaur P, Shukla S, Abbas A, Fu P, Gupta S (2012) Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog 51(12):952\u2013962. https:\/\/doi.org\/10.1002\/mc.20866","journal-title":"Mol Carcinog"},{"key":"3249_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030780","author":"K Pant","year":"2020","unstructured":"Pant K, Peixoto E, Richard S, Gradilone SA (2020) Role of histone deacetylases in carcinogenesis: potential role in cholangiocarcinoma. Cells. https:\/\/doi.org\/10.3390\/cells9030780","journal-title":"Cells"},{"issue":"2","key":"3249_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Kim J-S (2020) A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med 52(2):204\u2013212. https:\/\/doi.org\/10.1038\/s12276-020-0382-4","journal-title":"Exp Mol Med"},{"issue":"16","key":"3249_CR44","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26(16):1781\u20131802. https:\/\/doi.org\/10.1002\/jcc.20289","journal-title":"J Comput Chem"},{"key":"3249_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sbi.2019.01.004","volume":"59","author":"NJ Porter","year":"2019","unstructured":"Porter NJ, Christianson DW (2019) Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases. Curr Opin Struct Biol 59:9\u201318. https:\/\/doi.org\/10.1016\/j.sbi.2019.01.004","journal-title":"Curr Opin Struct Biol"},{"key":"3249_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fct.2013.04.052","volume":"60","author":"AJ Roy","year":"2013","unstructured":"Roy AJ, Stanely Mainzen Prince P (2013) Preventive effects of p-coumaric acid on cardiac hypertrophy and alterations in electrocardiogram, lipids, and lipoproteins in experimentally induced myocardial infarcted rats. Food Chem Toxicol 60:348\u2013354. https:\/\/doi.org\/10.1016\/j.fct.2013.04.052","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"3249_CR47","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.celrep.2017.01.055","volume":"18","author":"A Saunders","year":"2017","unstructured":"Saunders A, Huang X, Fidalgo M, Reimer MH, Faiola F, Ding J, S\u00e1nchez-Priego C, Guallar D, S\u00e1enz C, Li D, Wang J (2017) The SIN3A\/HDAC corepressor complex functionally cooperates with NANOG to promote pluripotency. Cell Rep 18(7):1713\u20131726. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.055","journal-title":"Cell Rep"},{"key":"3249_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8120568","author":"B Scafuri","year":"2020","unstructured":"Scafuri B, Bontempo P, Altucci L, De Masi L, Facchiano A (2020) Molecular docking simulations on histone deacetylases (HDAC)-1 and -2 to investigate the flavone binding. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8120568","journal-title":"Biomedicines"},{"key":"3249_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bcp.2015.11.005","volume":"99","author":"C Seidel","year":"2016","unstructured":"Seidel C, Schnekenburger M, Mazumder A, Teiten M-H, Kirsch G, Dicato M, Diederich M (2016) 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90\u03b1 chaperone activity against prostate cancer. Biochem Pharmacol 99:31\u201352. https:\/\/doi.org\/10.1016\/j.bcp.2015.11.005","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"3249_CR50","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1139\/o07-145","volume":"85","author":"A Sekhavat","year":"2007","unstructured":"Sekhavat A, Sun J-M, Davie JR (2007) Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem Cell Biol 85(6):751\u2013758. https:\/\/doi.org\/10.1139\/o07-145","journal-title":"Biochem Cell Biol"},{"key":"3249_CR51","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1296.172962","author":"K Shimizu","year":"2015","unstructured":"Shimizu K, Mira A (2015) In vitro cytotoxic activities and molecular mechanisms of angelica shikokiana extract and its isolated compounds. Pharmacogn Mag. https:\/\/doi.org\/10.4103\/0973-1296.172962","journal-title":"Pharmacogn Mag"},{"key":"3249_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00537","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL (2020) Histone deacetylases inhibitors in neurodegenerative, diseases neuroprotection and neuronal differentiation. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.00537","journal-title":"Front Pharmacol"},{"key":"3249_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-8-7","author":"C Sim\u00f5es-Pires","year":"2013","unstructured":"Sim\u00f5es-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt P-A, Cuendet M (2013) HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-8-7","journal-title":"Mol Neurodegener"},{"issue":"3","key":"3249_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jsb.2016.06.023","volume":"195","author":"AA Tabackman","year":"2016","unstructured":"Tabackman AA, Frankson R, Marsan ES, Perry K, Cole KE (2016) Structure of \u2018linkerless\u2019 hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket. J Struct Biol 195(3):373\u2013378. https:\/\/doi.org\/10.1016\/j.jsb.2016.06.023","journal-title":"J Struct Biol"},{"issue":"26","key":"3249_CR55","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1002\/slct.202102061","volume":"6","author":"K Tilekar","year":"2021","unstructured":"Tilekar K, Hess JD, Upadhyay N, Schweipert M, Flath F, Gutierrez DA, Loiodice F, Lavecchia A, Meyer-Almes FJ, Aguilera RJ, Ramaa CS (2021) HDAC4 inhibitors with cyclic linker and non-hydroxamate zinc binding group: design, synthesis, HDAC screening and in vitro cytotoxicity evaluation. Chem Select 6(26):6748\u20136763. https:\/\/doi.org\/10.1002\/slct.202102061","journal-title":"Chem Select"},{"issue":"1","key":"3249_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7164\/antibiotics.29.1","volume":"29","author":"N Tsuji","year":"1976","unstructured":"Tsuji N, Kobayashi M, Nagashima K, Wakisaka Y, Koizumi K (1976) A new antifungal antibiotic, trichostatin. J Antibiot 29(1):1\u20136. https:\/\/doi.org\/10.7164\/antibiotics.29.1","journal-title":"J Antibiot"},{"issue":"12","key":"3249_CR57","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1080\/07391102.2017.1384402","volume":"36","author":"AI Uba","year":"2017","unstructured":"Uba AI, Yelek\u00e7i K (2017) Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. J Biomol Struct Dyn 36(12):3231\u20133245. https:\/\/doi.org\/10.1080\/07391102.2017.1384402","journal-title":"J Biomol Struct Dyn"},{"key":"3249_CR58","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3906\/biy-1701-26","volume":"41","author":"A\u0130 Uba","year":"2017","unstructured":"Uba A\u0130, Yelek\u00c7\u0130 K (2017) Exploration of the binding pocket of histone deacetylases: the design of potent and isoform-selective inhibitors. Turk J Biol 41:901\u2013918. https:\/\/doi.org\/10.3906\/biy-1701-26","journal-title":"Turk J Biol"},{"key":"3249_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.compbiolchem.2018.05.004","volume":"75","author":"AI Uba","year":"2018","unstructured":"Uba AI, Yelek\u00e7i K (2018a) Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: structure-based virtual screening, molecular docking and dynamics simulation studies. Comput Biol Chem 75:131\u2013142. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.05.004","journal-title":"Comput Biol Chem"},{"key":"3249_CR60","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.compbiolchem.2018.10.016","volume":"77","author":"AI Uba","year":"2018","unstructured":"Uba AI, Yelek\u00e7i K (2018b) Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6. Comput Biol Chem 77:318\u2013330. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.10.016","journal-title":"Comput Biol Chem"},{"issue":"15","key":"3249_CR61","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1080\/07391102.2019.1691658","volume":"38","author":"AI Uba","year":"2019","unstructured":"Uba AI, Yelek\u00e7i K (2019) Crystallographic structure versus homology model: a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10. J Biomol Struct Dyn 38(15):4397\u20134406. https:\/\/doi.org\/10.1080\/07391102.2019.1691658","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"3249_CR62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1159\/000495275","volume":"51","author":"S Venturelli","year":"2018","unstructured":"Venturelli S, Niessner H, Sinnberg T, Berger A, Burkard M, Urmann C, Donaubauer K, B\u00f6cker A, Leischner C, Riepl H, Frank J, Lauer Ulrich M, Garbe C, Busch C (2018) 6- and 8-prenylnaringenin, novel natural histone deacetylase inhibitors found in hops, exert antitumor activity on melanoma cells. Cell Physiol Biochem 51(2):543\u2013556. https:\/\/doi.org\/10.1159\/000495275","journal-title":"Cell Physiol Biochem"},{"key":"3249_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nepig.2014.10.002","volume":"1","author":"C-H Volmar","year":"2015","unstructured":"Volmar C-H, Wahlestedt C (2015) Histone deacetylases (HDACs) and brain function. Neuroepigenetics 1:20\u201327. https:\/\/doi.org\/10.1016\/j.nepig.2014.10.002","journal-title":"Neuroepigenetics"},{"issue":"22","key":"3249_CR64","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1016\/j.bmc.2013.09.021","volume":"21","author":"F Wang","year":"2013","unstructured":"Wang F, Lu W, Zhang T, Dong J, Gao H, Li P, Wang S, Zhang J (2013) Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors. Bioorg Med Chem 21(22):6973\u20136980. https:\/\/doi.org\/10.1016\/j.bmc.2013.09.021","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"3249_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.bbrc.2018.08.043","volume":"504","author":"XN Wang","year":"2018","unstructured":"Wang XN, Wang KY, Zhang XS, Yang C, Li XY (2018) 4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2\/p53 pathway. Biochem Biophys Res Commun 504(4):812\u2013819. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.043","journal-title":"Biochem Biophys Res Commun"},{"key":"3249_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1127-7","author":"P Wang","year":"2020","unstructured":"Wang P, Wang Z, Liu J (2020) Role of HDACs in normal and malignant hematopoiesis. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-019-1127-7","journal-title":"Mol Cancer"},{"issue":"7381","key":"3249_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10728","volume":"481","author":"PJ Watson","year":"2012","unstructured":"Watson PJ, Fairall L, Santos GM, Schwabe JWR (2012) Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481(7381):335\u2013340. https:\/\/doi.org\/10.1038\/nature10728","journal-title":"Nature"},{"key":"3249_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11262","author":"PJ Watson","year":"2016","unstructured":"Watson PJ, Millard CJ, Riley AM, Robertson NS, Wright LC, Godage HY, Cowley SM, Jamieson AG, Potter BVL, Schwabe JWR (2016) Insights into the activation mechanism of class I HDAC complexes by inositol phosphates. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms11262","journal-title":"Nat Commun"},{"key":"3249_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107244","author":"J Weako","year":"2020","unstructured":"Weako J, Uba AI, Keskin \u00d6, G\u00fcrsoy A, Yelek\u00e7i K (2020) Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: structure-based virtual screening, ADMET prediction and molecular dynamics studies. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107244","journal-title":"Comput Biol Chem"},{"key":"3249_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118211","author":"W Yan","year":"2020","unstructured":"Yan W, Wu THY, Leung SSY, To KKW (2020) Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylases. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.118211","journal-title":"Life Sci"},{"issue":"4","key":"3249_CR71","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1073\/pnas.98.4.1454","volume":"98","author":"A You","year":"2001","unstructured":"You A, Tong JK, Grozinger CM, Schreiber SL (2001) CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci 98(4):1454\u20131458. https:\/\/doi.org\/10.1073\/pnas.98.4.1454","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3249_CR72","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1074\/jbc.C500241200","volume":"281","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Gilquin B, Khochbin S, Matthias P (2006) Two catalytic domains are required for protein deacetylation. J Biol Chem 281(5):2401\u20132404. https:\/\/doi.org\/10.1074\/jbc.C500241200","journal-title":"J Biol Chem"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-023-03249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-023-03249-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-023-03249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T04:35:25Z","timestamp":1686112525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-023-03249-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,12]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1007\/s00726-023-03249-6","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,12]]},"assertion":[{"value":"26 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}